Global Dementia Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Dementia Drugs

• 1.1 Definition of Dementia Drugs
• 1.2 Dementia Drugs Segment by Type
  • 1.2.1 Global Dementia Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 MAO Inhibitors
  • 1.2.3 Cholinesterase Inhibitors
  • 1.2.4 Glutamate Inhibitors
• 1.3 Dementia Drugs Segment by Applications
  • 1.3.1 Global Dementia Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Others
• 1.4 Global Dementia Drugs Overall Market
  • 1.4.1 Global Dementia Drugs Revenue (2014-2025)
  • 1.4.2 Global Dementia Drugs Production (2014-2025)
  • 1.4.3 North America Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Dementia Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Dementia Drugs
• 2.3 Manufacturing Process Analysis of Dementia Drugs
• 2.4 Industry Chain Structure of Dementia Drugs

3 Development and Manufacturing Plants Analysis of Dementia Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Dementia Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Dementia Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Dementia Drugs Production and Capacity Analysis
• 4.2 Dementia Drugs Revenue Analysis
• 4.3 Dementia Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Dementia Drugs Regional Market Analysis

• 5.1 Dementia Drugs Production by Regions
  • 5.1.1 Global Dementia Drugs Production by Regions
  • 5.1.2 Global Dementia Drugs Revenue by Regions
• 5.2 Dementia Drugs Consumption by Regions
• 5.3 North America Dementia Drugs Market Analysis
  • 5.3.1 North America Dementia Drugs Production
  • 5.3.2 North America Dementia Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Dementia Drugs Import and Export
• 5.4 Europe Dementia Drugs Market Analysis
  • 5.4.1 Europe Dementia Drugs Production
  • 5.4.2 Europe Dementia Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Dementia Drugs Import and Export
• 5.5 China Dementia Drugs Market Analysis
  • 5.5.1 China Dementia Drugs Production
  • 5.5.2 China Dementia Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Dementia Drugs Import and Export
• 5.6 Japan Dementia Drugs Market Analysis
  • 5.6.1 Japan Dementia Drugs Production
  • 5.6.2 Japan Dementia Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Dementia Drugs Import and Export
• 5.7 Southeast Asia Dementia Drugs Market Analysis
  • 5.7.1 Southeast Asia Dementia Drugs Production
  • 5.7.2 Southeast Asia Dementia Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Dementia Drugs Import and Export
• 5.8 India Dementia Drugs Market Analysis
  • 5.8.1 India Dementia Drugs Production
  • 5.8.2 India Dementia Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Dementia Drugs Import and Export

6 Dementia Drugs Segment Market Analysis (by Type)

• 6.1 Global Dementia Drugs Production by Type
• 6.2 Global Dementia Drugs Revenue by Type
• 6.3 Dementia Drugs Price by Type

7 Dementia Drugs Segment Market Analysis (by Application)

• 7.1 Global Dementia Drugs Consumption by Application
• 7.2 Global Dementia Drugs Consumption Market Share by Application (2014-2019)

8 Dementia Drugs Major Manufacturers Analysis

• 8.1 Eisai, Inc
  • 8.1.1 Eisai, Inc Dementia Drugs Production Sites and Area Served
  • 8.1.2 Eisai, Inc Product Introduction, Application and Specification
  • 8.1.3 Eisai, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Janssen Pharmaceuticals, Inc
  • 8.2.1 Janssen Pharmaceuticals, Inc Dementia Drugs Production Sites and Area Served
  • 8.2.2 Janssen Pharmaceuticals, Inc Product Introduction, Application and Specification
  • 8.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Biogen Pharmaceuticals
  • 8.3.1 Biogen Pharmaceuticals Dementia Drugs Production Sites and Area Served
  • 8.3.2 Biogen Pharmaceuticals Product Introduction, Application and Specification
  • 8.3.3 Biogen Pharmaceuticals Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Forest Laboratories, Inc
  • 8.4.1 Forest Laboratories, Inc Dementia Drugs Production Sites and Area Served
  • 8.4.2 Forest Laboratories, Inc Product Introduction, Application and Specification
  • 8.4.3 Forest Laboratories, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Eli Lilly and Company
  • 8.5.1 Eli Lilly and Company Dementia Drugs Production Sites and Area Served
  • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.5.3 Eli Lilly and Company Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Novartis AG
  • 8.6.1 Novartis AG Dementia Drugs Production Sites and Area Served
  • 8.6.2 Novartis AG Product Introduction, Application and Specification
  • 8.6.3 Novartis AG Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sanofi S.A
  • 8.7.1 Sanofi S.A Dementia Drugs Production Sites and Area Served
  • 8.7.2 Sanofi S.A Product Introduction, Application and Specification
  • 8.7.3 Sanofi S.A Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 AstraZeneca GmbH
  • 8.8.1 AstraZeneca GmbH Dementia Drugs Production Sites and Area Served
  • 8.8.2 AstraZeneca GmbH Product Introduction, Application and Specification
  • 8.8.3 AstraZeneca GmbH Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 F. Hoffmann-La Roche
  • 8.9.1 F. Hoffmann-La Roche Dementia Drugs Production Sites and Area Served
  • 8.9.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.9.3 F. Hoffmann-La Roche Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Merck & Co., Inc
  • 8.10.1 Merck & Co., Inc Dementia Drugs Production Sites and Area Served
  • 8.10.2 Merck & Co., Inc Product Introduction, Application and Specification
  • 8.10.3 Merck & Co., Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Valeant Pharmaceutical International
• 8.12 Pfizer Inc
• 8.13 Teva Pharmaceuticals Industries

9 Development Trend of Analysis of Dementia Drugs Market

• 9.1 Global Dementia Drugs Market Trend Analysis
  • 9.1.1 Global Dementia Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Dementia Drugs Regional Market Trend
  • 9.2.1 North America Dementia Drugs Forecast 2019-2025
  • 9.2.2 Europe Dementia Drugs Forecast 2019-2025
  • 9.2.3 China Dementia Drugs Forecast 2019-2025
  • 9.2.4 Japan Dementia Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Dementia Drugs Forecast 2019-2025
  • 9.2.6 India Dementia Drugs Forecast 2019-2025
• 9.3 Dementia Drugs Market Trend (Product Type)
• 9.4 Dementia Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Dementia Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List